Massachusetts cannabis regulators have fined two prominent companies, Ascend Wellness Holdings AAWH AAWH and Curaleaf Holdings CURA CURLF, for violations related to consumer safety practices. The fines, totaling $165,000, were issued after both companies self-reported the incidents, according to The Boston Globe.
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can’t afford to miss out if you're serious about the business.
Ascend Wellness Faces Track-and-Trace Compliance Issues
Ascend Wellness, which operates three dispensaries in the state, was fined $85,000 for failing to properly comply with Massachusetts’ track-and-trace system. Regulators were unable to verify the delivery of nearly 900 cannabis products due to discrepancies in Ascend’s tracking processes.
The state's Cannabis Control Commission (CCC) deemed the violations significant, but Ascend's president and co-founder, Frank Perullo, reassured that the company has implemented corrective measures. “Ascend is fully committed to adhering to the regulations set forth by the CCC and places great importance on compliance,” Perullo said in a statement. “We have already implemented most of the necessary actions and remain dedicated to restoring trust.”
Read Also: Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?
Curaleaf Placed On Probation After Contamination Issues
Curaleaf, another major player in the Massachusetts cannabis industry, was fined $80,000 for not adhering to best practices in preventing contamination at its cultivation sites in Amesbury and Webster. Violations, dating back to 2021, included facility maintenance issues such as unsecured doors and gaps in ducts.
The CCC placed Curaleaf on a six-month probation, during which the company must report any pesticide detection and could be subject to third-party testing to ensure compliance.
In response, Curaleaf expressed its dedication to customer safety. “The health and safety of our patients and customers remains our number one priority,” the company said, adding that they have made necessary changes to prevent future issues.
Both companies have committed to improving their operations and working closely with regulators to ensure compliance moving forward.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.